Add
MNOV to Portfolio
Set Alert
Email to a
Friend
| |||
|
|
Quotes & Info
|
| MNOV > SEC Filings for MNOV > Form 8-K on 13-Jul-2009 | All Recent SEC Filings |
13-Jul-2009
Other Events, Financial Statements and Exhibits
On July 13, 2009, MediciNova, Inc. issued a press release (the "Press Release") announcing the proposed final protocol for its Phase II clinical trial (MN-221-CL-007) evaluating the safety and efficacy of MN-221 in patients with severe, acute exacerbations of asthma. A copy of the Press Release is attached hereto as Exhibit 99.1.
The information in this Current Report on Form 8-K being provided under this Item 8.01, including Exhibit 99.1 furnished herewith, is being furnished and shall not be deemed "filed" for any purpose of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of such Section. The information in this current report on Form 8-K shall not be deemed to be incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.
(d) Exhibits.
99.1 Press Release dated July 13, 2009.
|
|